Italy
Finasteride
March 26, 2007. Italian Competition Authority.
ANTITRUST AUTHORITY RULES MERCK MUST GRANT FREE LICENCES FOR THE ACTIVE INGREDIENT FINASTERIDE.
Imipenem Cilastatin
February 28, 2007.
Excerpt from Merck's SEC form 10-K describing the compulsory license.
January 2007. Van Bael and Bellis on Competition Law.
Merck presents commitments to the Italian Competition Authority.
June 21, 2005. Italian Competition Authority.
Pharmaceuticals: Antitrust Obliges Merck to License Manufacture of the Antibiotic
Imipenem Cilastatine.
Sumatriptan Succinate
February 26, 2006. Italian Competition Authority press release.
Pharmaceuticals: Antitrust says Glaxo has made amends and abuse of dominant position discontinued
- Granting of licence opens way for manufacture of generic migraine drugs.
Analysis of Competition Policy
December, 2005. Alain Georges and Matteo F. Bay for the Intellectual Property &
Technology Law Journal.
Essential Facilities: A Doctrine Clearly in Need of Limiting Principles?
No date. Global Competition Review.
Dominance in Italy
